-
1 Comment
Merit Medical Systems, Inc is currently in a long term uptrend where the price is trading 11.7% above its 200 day moving average.
From a valuation standpoint, the stock is 99.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.4.
Merit Medical Systems, Inc's total revenue rose by 0.0% to $258M since the same quarter in the previous year.
Its net income has increased by 465.7% to $15M since the same quarter in the previous year.
Finally, its free cash flow grew by 336.4% to $27M since the same quarter in the previous year.
Based on the above factors, Merit Medical Systems, Inc gets an overall score of 5/5.
Sector | Healthcare |
---|---|
ISIN | US5898891040 |
CurrencyCode | EUR |
Exchange | F |
Industry | Medical Instruments & Supplies |
Market Cap | 4B |
---|---|
Beta | 0.99 |
Dividend Yield | 0.0% |
Target Price | 76.22 |
PE Ratio | 59.75 |
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. It operates in two segments, Cardiovascular and Endoscopy. The company provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coated tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate strictures; gastroenterology products; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for MM3.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024